📈 economics

Towards Optimal Estimators for Randomized Control Trials

This paper proposes a principled framework using sample splitting to identify optimal estimators for families of randomized controlled trials based on specific analytical goals, demonstrating that the best choice varies between weighted least squares for inference and difference-in-means for decision-making contexts.

Original authors: Harsh Parikh, Gabriel Levin-Konigsberg, Nilesh Tripuraneni, Dhruv Madeka, Michael I. Jordan, Dean Foster, Dominique Perrault-Joncas, Alexander Volfovsky

Published 2026-07-28

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Harsh Parikh, Gabriel Levin-Konigsberg, Nilesh Tripuraneni, Dhruv Madeka, Michael I. Jordan, Dean Foster, Dominique Perrault-Joncas, Alexander Volfovsky

Original paper licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine you are a detective trying to solve a mystery: "Did the new clue actually change the outcome?" In the world of science, especially when testing new medicines, apps, or policies, the gold standard for solving this mystery is something called a Randomized Controlled Trial (RCT). Think of it like a perfectly fair coin toss. You split a group of people into two teams: Team A gets the new thing (the treatment), and Team B gets nothing or the old thing (the control). Because the teams were chosen by a coin flip, any difference in their results is likely due to the new thing, not because one team was naturally smarter or luckier.

For a long time, scientists have had a simple, go-to tool to measure that difference: they just average the results of Team A and subtract the average of Team B. It's like counting how many apples Team A ate versus Team B and finding the difference. This method is honest and unbiased, meaning it doesn't lie, but it can be a bit clumsy. If the data is messy—like if one person ate a hundred apples while everyone else ate one, or if the effects vary wildly from person to person—this simple average can be imprecise. It's like trying to hear a whisper in a storm; you might get the general idea, but you miss the details.

Over the years, scientists have invented dozens of fancy new tools to make these measurements sharper. Some tools use complex math to adjust for background details, while others use machine learning to predict what might have happened. But here is the tricky part: no single tool works best for every single mystery. Sometimes the fancy tool is a genius; other times, it overcomplicates things and makes a mess. The big question has been: "How do we know which tool to pick for our specific experiment without just guessing or picking the one that gives us the result we want?"

This paper, titled "Towards Optimal Estimators for Randomized Control Trials," tackles that exact problem. The authors, a team of researchers from Amazon, Google, Yale, and other institutions, propose a new way to decide which tool is the best. Instead of trying to find one "magic bullet" that works for every experiment ever, they suggest looking at families of similar experiments to see which tool performs best on average for a specific goal.

The researchers tested their idea using two real-world sets of data. First, they looked at 556 experiments Amazon ran to improve its supply chain, focusing on financial outcomes. Second, they analyzed 25 experiments from the "Strengthening Democracy Challenge," which tested different ways to influence political attitudes. They compared several different mathematical methods (estimators) against each other using two different goals: one goal was to get the most precise number possible (like a scientist wanting to publish a paper), and the other was to make the best decision possible (like a manager deciding whether to launch a new product).

What they found was a bit of a plot twist. The tool that was best at getting a precise number was often the worst tool for making a good decision, and vice versa. For the Amazon supply chain experiments, if the goal was to measure the exact size of the effect, a complex method called "Linear T-learner" with some data cleaning worked best. However, if the goal was simply to decide whether to launch a new policy (where the risk of making a wrong choice is the main concern), the simple, old-fashioned "Difference-in-Means" method was actually the champion. It turned out that the fancy tools, while precise, sometimes made the decision-making process too cautious or too risky.

Similarly, in the democracy experiments, the best tool depended entirely on what kind of data they were looking at. For some political questions, the simple average was fine, but for others, adjusting for background details made a huge difference. The paper suggests that there is no single "best" method for everyone. Instead, the right choice depends on what you are trying to achieve. If you want to know the exact truth, you might need a complex, data-heavy approach. But if you need to make a quick, safe decision about whether to do something, a simpler, more robust method might actually save you from costly mistakes.

The authors emphasize that this isn't just a theoretical idea; they used a clever statistical trick called "sample splitting" to test these methods on real data without cheating. They showed that by being honest about what your goal is—whether it's scientific precision or practical decision-making—you can pick the right tool for the job. This approach helps scientists and companies avoid the trap of picking a method just because it sounds cool or because it gives a result they like. Instead, it encourages them to match their method to their mission, ensuring that their experiments lead to better, more reliable conclusions in the real world.

Technical Summary: Towards Optimal Estimators for Randomized Control Trials

Problem Statement

Randomized Controlled Trials (RCTs) are the gold standard for causal inference, yet the standard Difference-in-Means (DM) estimator, while unbiased, often lacks precision, particularly when treatment effects are heterogeneous or outcomes exhibit heavy-tailed distributions. While numerous precision-enhancing methods exist (e.g., covariate adjustment, variance reduction, machine learning-based meta-learners), there is no universal "optimal" estimator that performs best across all datasets.

A critical challenge arises in the selection of estimators for families of related RCTs. Selecting an estimator on a case-by-case basis risks compromising scientific validity, as researchers may inadvertently select methods that support preferred narratives rather than those providing reliable inference. Furthermore, existing validation approaches, such as synthetic data generation, suffer from limitations where performance rankings on synthetic data diverge significantly from real-world applications, and they lack theoretical guarantees regarding the relationship between synthetic and real performance. The paper addresses the gap in providing principled guidance for estimator selection that accounts for specific research contexts, outcome characteristics, and analytical goals (inference vs. decision-making).

Methodology

The authors propose a general framework for identifying optimal estimators within families of related RCTs by leveraging the collection of real-world experiments rather than synthetic data.

1. Framework Setup

The framework considers a collection of $N$ studies drawn from a superpopulation. Each study involves comparing treatment pairs within a specific population. Key assumptions include:

Randomization: Treatment assignment is randomized within each study.
Study Independence: Conditional on covariates, potential outcomes are independent of study membership (studies differ only in covariate distributions, not causal mechanisms).
Non-overlapping Samples: Units participate in at most one study.

2. Performance Metrics

The framework distinguishes between two primary analytical goals, defining specific metrics for each:

Inference-Focused (Parameter Estimation): Uses Mean Squared Error (MSE) to quantify the discrepancy between the estimated treatment effect and the true effect, capturing both bias and variance.
Decision-Making Focused (Rollout Decisions): Uses Regret, defined as the economic opportunity cost of suboptimal decisions. Regret quantifies the cost of false negatives (failing to roll out beneficial treatments) and false positives (rolling out ineffective treatments) based on a decision rule involving a critical threshold $c$ .

3. Estimator Comparison via Sample Splitting

Since true treatment effects are unknown, the authors employ a cross-fitting (sample-splitting) procedure to estimate performance metrics without overfitting:

For each study $s$ , the sample is partitioned into $K$ folds.
One fold is used to compute a "ground truth" estimate using the unbiased DM estimator ( $\hat{\tau}_{DM}$ ).
The remaining folds are used to compute the estimator of interest ( $\hat{\tau}_{\alpha}$ ).
Performance metrics ( $\Delta$ ) are calculated between the cross-fitted estimator and the DM estimate.
The overall performance is aggregated across the family of studies.

Theoretical results (Theorems 4.1–4.3) establish that the cross-fitted MSE statistic is unbiased, and the regret-based statistic is asymptotically unbiased under regularity conditions.

4. Statistical Inference

To compare estimators, the authors utilize Permutation Tests rather than relying solely on asymptotic normality, which is complicated by the discontinuities in regret metrics and study heterogeneity. Under the null hypothesis of equal performance, estimator labels are permuted across studies to generate a null distribution for the test statistic, ensuring robust statistical validity.

5. Robustness via Weighted Metrics

To address sensitivity to outlier studies with high variance, the framework incorporates inverse-variance weighting. This assigns higher weight to studies with more precise estimates (larger sample sizes, lower outcome variance), balancing the influence of high-variance outliers while maintaining the use of all available data.

Key Contributions

Principled Framework for Estimator Selection: The paper shifts the focus from finding a single best estimator for individual RCTs to identifying superior approaches for entire families of related trials. It provides a systematic method to compare estimators while preserving scientific integrity.
Alignment of Metrics with Objectives: The work explicitly distinguishes between inference goals (minimizing MSE) and decision-making goals (minimizing regret), demonstrating that the optimal estimator depends critically on the intended use of the estimates.
Real-World Validation: Unlike synthetic data approaches, the framework evaluates estimators on collections of real RCTs sharing common outcome measures, providing stronger assurance regarding cross-context generalizability.
Practical Implementation: The authors provide a practical, implementable framework that practitioners can apply across diverse experimental contexts, including business and social science settings.

Empirical Results

The framework was applied to two distinct datasets:

1. Amazon Supply Chain Optimization Technology (SCOT)

Data: 556 RCTs focused on financial outcomes with heavy-tailed distributions.
Estimators Evaluated: DM, OLS, Linear T-learner, and Weighted Least Squares (WLS), combined with various levels of winsorization.
Findings:
- Inference (MSE): The Linear T-learner with 0.5% winsorization achieved the minimum MSE. However, for lower winsorization levels, OLS was optimal.
- Decision-Making (Regret): The standard Difference-in-Means (DM) without winsorization achieved the best performance (minimum regret). The estimator with the lowest MSE (Linear T-learner) performed suboptimally for decision-making.
- Implication: Estimators minimizing estimation error do not necessarily minimize decision costs. For launch decisions, simple DM is preferred; for uplift measurement, covariate-adjusted methods are superior.

2. Strengthening Democracy Challenge (SDC)

Data: 25 interventions targeting political attitudes and behaviors (e.g., support for partisan violence, partisan animosity).
Findings:
- Inference (MSE): Optimal estimators varied by outcome. For outcomes with weak covariate relationships and heavy tails (e.g., Support for Partisan Violence), aggressive winsorization (10%) with OLS was optimal. For outcomes with strong covariate associations (e.g., Partisan Animosity), covariate adjustment without heavy winsorization was superior.
- Decision-Making (Regret): Across all outcomes, estimators performed nearly identically, with DM_0 achieving minimum normalized regret.
- Implication: The divergence between MSE and regret rankings reinforces that optimal strategies are context-dependent. For rollout decisions, simple methods often suffice, whereas inference requires tailored adjustment and trimming.

Significance and Claims

The paper claims to offer a "principled alternative to ad hoc estimator selection" that preserves scientific integrity while accommodating methodological flexibility. Its primary significance lies in demonstrating that:

No Universal Optimal Estimator Exists: The "best" estimator is contingent on the analytical objective (inference vs. decision) and the specific distributional properties of the outcome data.
Metric Selection is Critical: The focus on p-values or MSE alone may not translate to optimal decision-making performance. Organizations must explicitly prioritize their objectives (scientific understanding vs. operational deployment) to select appropriate methods.
Domain-Specific Best Practices: Rather than relying on general-purpose recommendations, research communities and organizations should develop domain-specific validation frameworks using accumulated experimental data to guide method selection.

The authors conclude that while their framework addresses current limitations, future work is needed to extend these methods to time-varying treatments, factorial designs, and settings with interference or non-compliance. They emphasize that the goal is not to find a single "best" method, but to develop principled approaches for selecting methods well-suited to specific research contexts.